Virtual EFORT Congress (VEC)
Main theme: Harmonisation & Diversity

Nested Applications

VEC Exhibitors 2020

CORPORATE INFORMATION

Although the 21st EFORT Annual Congress Vienna 2020 has been postponed until 2021, we are pleased to leave here the links and information of our existing corporate partners and exhibitors.

EFORT invites you to browse through the Exhibitors Database of the 21st EFORT Annual Congress 2020 which represents those exhibitors that have committed to and confirmed their presence at the 2020 EFORT Congress.

EFORT Industry Database


REV-MED, Inc.

#306, Dream techno, 464, Dunchon-daero, Jungwon-gu,
13229 Seongnam-si, Gyeonggi-do
South Korea
Phone: +49 89 237 625-40
e-Mail: info@rev-med.com
About Us

REV-MED produces and markets the TriCell Biologic Separation & Concentration System.

The TriCell System is designed to separate autologous peripheral blood or bone marrow into its essential elements. The TriCell triple chamber technology allows for accurate customized control over the biologic. The physician can easily specify and control the final concentration and cellular constellation to meet the therapeutic demand.

Area of Business: Medical Industry
Category: Medical Devices
Number of Employees worldwide: 2-10 employees
Founded in: 2016
Products
No products found.
Industry Symposium
No activities found.

Hospitality Suite
No activities found.

Scientific Session
No activities found.